The certification validates the Niagara site’s adherence to rigorous international quality and safety standards, which serves as a primary gatekeeper for entry into European supply chains. Aurora Cannabis acquired the facility in April 2026 specifically to bolster its global manufacturing footprint and meet the rising demand for consistent, high-grade medical cannabis products.

Brigitte Simons, CEO of Safari Flower Company, stated that the achievement reflects a deep-seated culture of compliance and operational discipline. The company intends to leverage this regulatory status to maintain its position as a reliable supplier in markets where strict adherence to manufacturing protocols is non-negotiable for patient access.